Biomet Posts Narrower FQ4 Loss

Biomet reported a narrower fiscal fourth-quarter loss. Biomet posted a quarterly loss of $388.1 million, versus a year-ago loss of $812.8 million. Excluding special items, Biomet's adjusted earnings surged to $105.6 million from $24.6 million. Its net sales rose 3.4% to $739.5 million, while gross margin gained to 69.6% from 68%. US sales climbed 6.8%, while sales in Europe declined 8.2%.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: EarningsNewsloss
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!